Taken together, these data confirm the enhanced efficacy of CDK8/19is, particularly when combined with platinum-based chemotherapy, evidenced by the inhibition of tumor growth, decreased cellular proliferation and vascularity, and improved overall survival. This evidence concerns the gene CDK8 and neoplasm.